compare glp-1 medications Understanding Weight Loss Medications: vs. Phentermine GLP-1 Agonists for Weight Loss:
Description
More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture

Indications for sitagliptin include use in type 2 diabetes as monotherapy or in combination with metformin or thiazolidinediones

On 4 June 2021, the FDA approved semaglutide injections (2.4 mg/week) for weight management in obese patients 30 kg/m 2 BMI or overweight patients 27 kg/m 2 BMI with at least one weight-related condition, including high blood pressure, T2DM or hypercholesterolemia [139]

For a thorough comparison of how these two categories differ, the research versus pharmaceutical peptides comparison page provides essential context
Trial of lixisenatide in early Parkinsons disease

Boosting your bodys GLP-1 can provide benefits while helping you avoid some of the side effects of these medicines
